What is the share price of Tarsons Products Ltd (TARSONS) today?
The share price of TARSONS as on 5th December 2025 is ₹224.85. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Tarsons Products Ltd (TARSONS) share?
The past returns of Tarsons Products Ltd (TARSONS) share are- Past 1 week: 5.40%
- Past 1 month: -19.53%
- Past 3 months: -29.34%
- Past 6 months: -40.57%
- Past 1 year: -48.19%
- Past 3 years: -68.89%
- Past 5 years: -72.15%
What are the peers or stocks similar to Tarsons Products Ltd (TARSONS)?
The peers or stocks similar to Tarsons Products Ltd (TARSONS) include:What is the market cap of Tarsons Products Ltd (TARSONS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tarsons Products Ltd (TARSONS) is ₹1212.52 Cr as of 5th December 2025.What is the 52 week high and low of Tarsons Products Ltd (TARSONS) share?
The 52-week high of Tarsons Products Ltd (TARSONS) is ₹464.30 and the 52-week low is ₹198.What is the PE and PB ratio of Tarsons Products Ltd (TARSONS) stock?
The P/E (price-to-earnings) ratio of Tarsons Products Ltd (TARSONS) is 40.73. The P/B (price-to-book) ratio is 1.92.Which sector does Tarsons Products Ltd (TARSONS) belong to?
Tarsons Products Ltd (TARSONS) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Tarsons Products Ltd (TARSONS) shares?
You can directly buy Tarsons Products Ltd (TARSONS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Tarsons Products Ltd
TARSONS Share Price
224.851.33% (-3.04)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TARSONS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TARSONS Performance & Key Metrics
TARSONS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 59.00 | 1.92 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
100%
Analysts have suggested that investors can buy this stock
from 2 analysts
Price Upside
Earnings Growth
Rev. Growth
TARSONS Company Profile
Tarsons Products Limited is engaged in the designing, development, manufacturing of a range of labware products which helps scientific discovery and healthcare
PE Ratio
57.38
57.38
1Y Return
15.01%
15.01%
Buy Reco %
71.43
71.43
POLYMED
PE Ratio
57.21
57.21
1Y Return
33.55%
33.55%
Buy Reco %
66.67
66.67
FISCHER
PE Ratio
2,040.43
2,040.43
1Y Return
39.58%
39.58%
Buy Reco %
0.00
0.00
LAXMIDENTL
PE Ratio
47.65
47.65
1Y Return
49.96%
49.96%
Buy Reco %
100.00
100.00
BOROSCI
PE Ratio
40.94
40.94
1Y Return
31.97%
31.97%
Buy Reco %
0.00
0.00
TARSONS Sentiment Analysis
TARSONS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TARSONS Stock Summary · November 2025
The company has demonstrated resilience in its financial performance, reporting revenue and EBITDA growth despite facing challenges such as high borrowing costs and accelerated depreciation linked to ongoing capacity expansion. While the domestic market has shown stagnant revenue, optimism remains for future growth driven by strategic investments in new facilities and product launches, particularly in the plastic labware segment. The management is focused on enhancing operational efficiencies and maintaining strong customer relationships, especially in export markets, despite logistical hurdles. As the company ramps up production capacity, it aims to leverage its brand recognition and deepen market penetration, positioning itself for long-term growth in a competitive landscape.
TARSONS Stock Growth Drivers
TARSONS Stock Growth Drivers
6Revenue and Profitability Growth
The company has reported consistent revenue and EBITDA growth, with consolidated revenue for Q2 FY
Capacity Expansion and Operational Efficiency
The company is nearing completion of capacity expansions at the Panchla and Amta facilities, expected
TARSONS Stock Challenges
TARSONS Stock Challenges
6Decline in Profitability
The company reported a decrease in profit after tax (PAT) for Q2 FY '26, which
Export Challenges
There was a noted drop in exports for Q2, attributed to large shipments being withheld
TARSONS Forecast
TARSONS Forecasts
Price
Revenue
Earnings
TARSONS Share Price Forecast
TARSONS Share Price Forecast
2025
Current
₹227.89
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹227.89
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS Company Revenue Forecast
TARSONS Company Revenue Forecast
2025
Current
₹408.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹408.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
TARSONS Stock EPS (Earnings Per Share) Forecast
TARSONS Stock EPS (Earnings Per Share) Forecast
2025
Current
₹5.60
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹5.60
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS
TARSONS
Income
Balance Sheet
Cash Flow
Annual Normal View
TARSONS Income Statement
TARSONS Income Statement
Annual Normal View
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 307.87 | 408.37 | 415.83 | |||
Raw Materials | 79.27 | 131.05 | 283.26 | |||
| Power & Fuel Cost | 10.88 | 13.18 | ||||
| Employee Cost | 44.27 | 65.38 | ||||
| Selling & Administrative Expenses | 26.44 | 26.49 | ||||
| Operating & Other expenses | 35.69 | 45.43 | ||||
EBITDA | 111.32 | 126.84 | 132.57 | |||
| Depreciation/Amortization | 40.40 | 62.50 | 79.86 | |||
| PBIT | 70.92 | 64.34 | 52.71 | |||
| Interest & Other Items | 10.15 | 19.54 | 20.48 | |||
| PBT | 60.77 | 44.80 | 32.23 | |||
| Taxes & Other Items | 18.13 | 15.03 | 11.68 | |||
| Net Income | 42.64 | 29.77 | 20.55 | |||
| EPS | 8.01 | 5.60 | 3.86 | |||
| DPS | 2.00 | 0.00 | 0.00 | |||
| Payout ratio | 0.25 | 0.00 | 0.00 |
TARSONS Company Updates
FY 2026FY 2026
Investor Presentation
Nov 12PDF
Aug 12PDF
TARSONS Stock Peers
TARSONS Past Performance & Peer Comparison
TARSONS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tarsons Products Ltd | 40.73 | 1.92 | — |
| Inventurus Knowledge Solutions Ltd | 57.38 | 15.58 | — |
| Poly Medicure Ltd | 57.21 | 7.00 | 0.18% |
| Fischer Medical Ventures Ltd | 2,040.43 | 9.00 | 0.10% |
TARSONS Stock Price Comparison
Compare TARSONS with any stock or ETFCompare TARSONS with any stock or ETF
TARSONS
TARSONS Holdings
TARSONS Shareholdings
TARSONS Promoter Holdings Trend
TARSONS Promoter Holdings Trend
TARSONS Institutional Holdings Trend
TARSONS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 3.31%
TARSONS Shareholding Pattern
TARSONS Shareholding Pattern
TARSONS Shareholding History
TARSONS Shareholding History
Foreign Institutions
Mutual Funds Invested in TARSONS
Mutual Funds Invested in TARSONS
No mutual funds holding trends are available
Top 2 Mutual Funds holding Tarsons Products Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 108/124 (-10) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 850/1023 (+112) |
Compare 3-month MF holding change on Screener
smallcases containing TARSONS stock
smallcases containing TARSONS stock
Looks like this stock is not in any smallcase yet.
TARSONS Events
TARSONS Events
TARSONS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TARSONS Dividend Trend
No dividend trend available
TARSONS Upcoming Dividends
TARSONS Upcoming Dividends
No upcoming dividends are available
TARSONS Past Dividends
TARSONS Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2024
TARSONS Stock News & Opinions
TARSONS Stock News & Opinions
Articles & Videos
Earnings
Tarsons Products consolidated net profit declines 67.74% in the September 2025 quarter
Net profit of Tarsons Products declined 67.74% to Rs 3.32 crore in the quarter ended September 2025 as against Rs 10.29 crore during the previous quarter ended September 2024. Sales rose 3.10% to Rs 102.33 crore in the quarter ended September 2025 as against Rs 99.25 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales102.3399.25 3 OPM %26.8225.49 - PBDT28.0728.90 -3 PBT5.5914.87 -62 NP3.3210.29 -68 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Tarsons Products standalone net profit declines 49.50% in the September 2025 quarter
Net profit of Tarsons Products declined 49.50% to Rs 6.53 crore in the quarter ended September 2025 as against Rs 12.93 crore during the previous quarter ended September 2024. Sales rose 0.49% to Rs 80.51 crore in the quarter ended September 2025 as against Rs 80.12 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales80.5180.12 0 OPM %32.4729.34 - PBDT29.0529.48 -1 PBT8.8817.52 -49 NP6.5312.93 -49 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Tarsons Products announces board meeting date
Tarsons Products will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Tarsons Products AGM scheduled
Tarsons Products announced that the 42th Annual General Meeting(AGM) of the company will be held on 22 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Tarsons Products consolidated net profit declines 55.72% in the June 2025 quarter
Net profit of Tarsons Products declined 55.72% to Rs 1.78 crore in the quarter ended June 2025 as against Rs 4.02 crore during the previous quarter ended June 2024. Sales rose 7.74% to Rs 91.36 crore in the quarter ended June 2025 as against Rs 84.80 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales91.3684.80 8 OPM %27.0422.11 - PBDT22.9717.35 32 PBT3.036.32 -52 NP1.784.02 -56 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Tarsons Products to discuss results
Tarsons Products will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
CareEdge Ratings reaffirms ratings of Tarsons Products with 'stable' outlook
The agency has also affirmed the company's short-term rating at 'CARE A1'. CareEdge Ratings stated that the reaffirmation of ratings assigned to bank facilities of Tarsons Products (TPL) considers improvement in scale of operation in FY25 with recovery in operating margin in H2FY25. The margin exhibited recovery from 25.5% in Q2 FY25 to 30.98% and 32.86% in Q3 FY25 and Q4 FY25, respectively. Ratings further consider comfortable capital structure and debt protection metrics despite slight moderation considering ongoing capex. Ratings continue to derive strength from the long track record and established brand presence of TPL in the domestic plastic laboratory ware industry aided by its diversified product portfolio, strong distribution network, and low exposure to foreign exchange fluctuation risk. The ratings continue to remain constrained by the modest scale of operations albeit expected improvement on back of acquisition and undergoing capex, which is expected to complete in FY26, susceptibility of its profitability to volatility in raw material prices, elongated working capital cycle and project implementation, and stabilisation risk in relation to the undergoing capex. Tarsons Products (TPL) is engaged in manufacturing and trading plastic laboratory products and certain scientific instruments, with six manufacturing facilities in West Bengal. The products find usage in laboratories engaged in research on molecular biology, cell culture, genomics, proteomics, and immunology, among others. The scrip rose 0.23% to currently trade at Rs 372.35 on the BSE. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Tarsons Products consolidated net profit declines 1.16% in the March 2025 quarter
Net profit of Tarsons Products declined 1.16% to Rs 10.20 crore in the quarter ended March 2025 as against Rs 10.32 crore during the previous quarter ended March 2024. Sales rose 6.59% to Rs 112.69 crore in the quarter ended March 2025 as against Rs 105.72 crore during the previous quarter ended March 2024. For the full year,net profit declined 30.18% to Rs 29.77 crore in the year ended March 2025 as against Rs 42.64 crore during the previous year ended March 2024. Sales rose 32.40% to Rs 392.41 crore in the year ended March 2025 as against Rs 296.39 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales112.69105.72 7 392.41296.39 32 OPM %32.8528.61 -28.2233.68 - PBDT35.6029.37 21 107.30101.17 6 PBT15.5717.04 -9 44.8060.77 -26 NP10.2010.32 -1 29.7742.64 -30 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Tarsons Products to table results
Tarsons Products will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Tarsons Products standalone net profit declines 24.43% in the December 2024 quarter
Net profit of Tarsons Products declined 24.43% to Rs 7.61 crore in the quarter ended December 2024 as against Rs 10.07 crore during the previous quarter ended December 2023. Sales rose 23.26% to Rs 76.16 crore in the quarter ended December 2024 as against Rs 61.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales76.1661.79 23 OPM %36.6637.03 - PBDT25.9123.75 9 PBT10.3013.69 -25 NP7.6110.07 -24 Powered by Capital Market - Live
9 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant